# Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

> **NCT00563823** · PHASE2 · COMPLETED · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 34 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DRUG:** vatalanib

## Key facts

- **NCT ID:** NCT00563823
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-09
- **Final completion:** 2010-10
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2013-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563823, "Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00563823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*